Xavier Fustà-Novell

Dr. Xavier Fustà-Novell

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2020 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
CGCristina Galvan
Cristina Galvan
ACA. Català
A. Català
GHG. Carretero Hernández
G. Carretero Hernández
PJPedro Rodriguez Jimenez
Pedro Rodriguez Jimenez
DFD. Fernández‐Nieto
D. Fernández‐Nieto
IGI. García‐Doval
I. García‐Doval
SummaryBackground. The cutaneous manifestations of COVID‐19 disease are poorly characterized.Objectives. To describe the cutaneous manifestations of COVID‐19 di

5 June 2017 in Photodermatology, Photoimmunology & Photomedicine
Verified
Journal Article
Closed access
PDF file
XFXavier Fustà-Novell
Xavier Fustà-Novell
Sebastian PodlipnikSebastian Podlipnik
Sebastian Podlipnik
ACAndrea Combalia
Andrea Combalia
DMDaniel Morgado‐Carrasco
Daniel Morgado‐Carrasco
JFJuan Ferrando
Juan Ferrando
PAPaula Aguilera
Paula Aguilera

31 August 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
ABAnna Escalé Besa
Anna Escalé Besa
AFAïna Fuster-Casanovas
Aïna Fuster-Casanovas
ABAlexander Börve
Alexander Börve
OYOriol Yélamos
Oriol Yélamos
XFXavier Fustà-Novell
Xavier Fustà-Novell
Josep Vidal-AlaballJosep Vidal-Alaball
Josep Vidal-Alaball
Background: Dermatological conditions are a relevant health problem. Each person has an average of 1.6 skin diseases per year, and consultations for skin pathology represent 20% of the total annual visits to primary care and around 35% are referred to a dermatology specialist. Machine learning (ML) models can be a good tool to help primary care professionals, as it can analyze and optimize complex sets of data. In addition, ML models are increasingly being applied to dermatology as a diagnostic decision support tool using image analysis, especially for skin cancer detection and classification. Objective: This study aims to perform a prospective validation of an image analysis ML model as a diagnostic decision support tool for the diagnosis of dermatological conditions. Methods: In this prospective study, 100 consecutive patients who visit a participant general practitioner (GP) with a skin problem in central Catalonia were recruited. Data collection was planned to last 7 months. Anonymized pictures of skin diseases were taken and introduced to the ML model interface (capable of screening for 44 different skin diseases), which returned the top 5 diagnoses by probability. The same image was also sent as a teledermatology consultation following the current stablished workflow. The GP, ML model, and dermatologist’s assessments will be compared to calculate the precision, sensitivity, specificity, and accuracy of the ML model. The results will be represented globally and individually for each skin disease class using a confusion matrix and one-versus-all methodology. The time taken to make the diagnosis will also be taken into consideration. Results: Patient recruitment began in June 2021 and lasted for 5 months. Currently, all patients have been recruited and the images have been shown to the GPs and dermatologists. The analysis of the results has already started. Conclusions: This study will provide information about ML models’ effectiveness and limitations. External testing is essential for regulating these diagnostic systems to deploy ML models in a primary care practice setting.

13 October 2017 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
Sebastian PodlipnikSebastian Podlipnik
Sebastian Podlipnik
DMD. Morgado-Carrasco
D. Morgado-Carrasco
XFXavier Fustà-Novell
Xavier Fustà-Novell
AMA. Mensa-Vilaró
A. Mensa-Vilaró
JAJ.I. Arostegui
J.I. Arostegui
Jose Manuel MascaroJose Manuel Mascaro
Jose Manuel Mascaro

29 June 2020 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
XFXavier Fustà-Novell
Xavier Fustà-Novell
DMDaniel Morgado-Carrasco
Daniel Morgado-Carrasco
AGA. García‐Herrera
A. García‐Herrera
XBX. Bosch‐Amate
X. Bosch‐Amate
IMI. Martí‐Martí
I. Martí‐Martí
CCCristina Carrera
Cristina Carrera

22 August 2019 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
XFXavier Fustà-Novell
Xavier Fustà-Novell
CLC. Riquelme‐Mc Loughlin
C. Riquelme‐Mc Loughlin
DMDaniel Morgado-Carrasco
Daniel Morgado-Carrasco
AGA. García‐Herrera
A. García‐Herrera
JMJ. M. Mascaró
J. M. Mascaró